Antiviral clinical trials taking place in Cleveland
By: Sylvia Rose
Posted: Mar 21, 2020 10:48 PM EDT
![](/images/abclogo_gray.png?x)
-
2:30
Mishawaka ‘Designated Outdoor Refreshment Area’ along riverwalk...
-
0:50
Saint Mary’s College breaks ground on Heritage and Research...
-
6:13
Rep. Rudy Yakym discusses Netanyahu’s address to Congress and...
-
3:41
Three civil rights lawsuits filed against Elkhart Police
-
1:03
The humidity returns, Sunday
-
1:57
Why the dew point is the best way to represent humidity
-
4:18
What is Project 2025 and why does it matter?
-
0:45
The South Bend Police Department hosts inaugural community track...
-
1:10
’A Rosie Place’ in South Bend welcomes new equine friend
-
1:42
Thanks to the weather, Michiana corn seeing rapid growth
-
4:10
Developing Downtowns: South Bend
-
2:25
After closure in 2020, YMCA reopens in downtown
CLEVELAND, Ohio – University Hospitals in Cleveland are taking the next step in fighting COVID-19, securing two clinical trials that will provide an antiviral drug to adults who have been hospitalized with pneumonia due to the virus.
Leaders of the study are hoping to test around 1000 people nationwide.
"Because there's no other treatment now so it's really exciting to see a drug that could hit the virus itself, not just supportive care," said Dr. Grace McComsey, a doctor at University Hospitals.
The trial should provide information on whether the drug can help lower fevers and normalize oxygen saturation in patients.
The drug is federally regulated and was safely tested on more than 500 people during the Ebola outbreak.
Sign up for the ABC 57Newsletter